Home › Glioblastoma › Alabama › Birmingham

Pag-aaral pangklinika para sa Glioblastoma sa Birmingham, AL

9 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Birmingham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Nagre-recruitPhase 2/3

University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT03970447

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Nagre-recruitPhase 2

University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07326566

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Nagre-recruitPhase 1/2

UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06914128

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Nagre-recruitPhase 1

University of Alabama at Birmingham Cancer Center, Birmingham

36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

University of Alabama, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Nagre-recruitPhase 2

University of Alabama at Birmingham Cancer Center, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06319027

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Nagre-recruit

University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT05297734

Study of Pembrolizumab and M032 (NSC 733972)

Nagre-recruitPhase 1/2

University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT05084430

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Glioblastoma sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.